Latest Breaking News On - Experimental therapeutics program - Page 1 : comparemela.com

First MYC inhibitor to demonstrate safety and anti-tumor activity in a phase I first-in-human clinical trial

First MYC inhibitor to demonstrate safety and anti-tumor activity in a phase I first-in-human clinical trial
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Laura soucekElena garraldaRaquel perez lopezEmiliano calvoRadiomics groupEarly clinical drug development groupExperimental therapeutics programModels of cancer therapies groupCatalan institute of researchUniversity hospitalsResearch unit for molecular therapy of cancerResearch professorTherapeutics programCancer therapies groupCatalan instituteAdvanced studie

Combination treatment improves lung cancer outcomes, finds study

Combination treatment improves lung cancer outcomes, finds study
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesNasser altorkiNasserk altorkiTimothy mcgrawDavidb skinnerZachary walshBenjamin izarPresbyterian weill cornell medical centerColumbia university vagelos college of physiciansNature communicationsNature communications on decNewyork presybeterian columbia university irving medical centerExperimental therapeutics programWeill cornell medicineColumbia university vagelos collegeThoracic surgery

Aliasger K Salem

Aliasger K. Salem’s profile on The Conversation

United statesUnited kingdomAliasger salemAmerican institute forProfessor of pharmaceutical sciencesLeadership in research awardAmerican association for the advancement of scienceResearch for the university of iowaAston university of scienceAmerican association for pharmaceutical scientistsDepartment of defenseAmerican cancer societyHolden comprehensive cancer centerJohns hopkins school of medicineNational institutes for healthUniversity of nottingham

Dr Komrokji on Ongoing Investigations With Luspatercept in MDS

Rami Komrokji, MD, discusses the benefit of agents such as luspatercept-aamt in patients with very low– to intermediate-risk myelodysplastic syndromes who have not received prior treatment with erythropoiesis-stimulating agents.

University of south floridaMoffitt cancer centerMedicine oncologic sciencesMalignant hematology departmentExperimental therapeutics programCollege of medicineRami komrokjiMalignant hematologyOncologic sciencesSouth floridaOnclive tv

New radiopharmaceutical shows antitumor activity in patients with advanced prostate cancer

New radiopharmaceutical shows antitumor activity in patients with advanced prostate cancer
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United statesScott tagawaConvergent therapeutics incExperimental therapeutics programAmerican cancer societyEdward meyer cancer centerPresbyterian weill cornell medical centerCornell universityEnglander institute of precision medicineTulane university school of medicineWeill cornell medicineNeil banderWeill cornell medicalAmerican cancerTulane university schoolEnglander institute